Abstract
ABSTRACT
 Introduction: Chronic Kidney Disease (CKD) and Chronic dialysis has a great impact on patients health-related quality of life (HRQOL). The impacts are about the morbidity, mortality, and the survival rate of the dialysis therapy. We focused this systematic review in Asian countries.
 Methods: Systematic Review with PRISMA method retrieved from online database such as PubMed, Wiley and ProQuest using a keyword “Health Related-Quality Life (HRQOL)”, “Chronic Kidney Disease (CKD) patient OR ESRD (End Stage Renal Disease), CKD with Hemodialysis OR CKD dialysis at Asian Country”. The end of this search we got 10 journals.
 Results: The measurement HRQOL in CKD or dyalisis patients such EQ-5D and Kidney Disease Quality of Life (KDQOL). There are 4 country used KDQL (Korea, China, India, Singapore and Indonesia). The result show HRQOL in CKD patients has declined when the level of CKD increased especially when the amount of albumin high and the level of hemoglobin decline. HRQOL in dialysis patient has lower depressive mood in planned dialysis group than unplanned dialysis. There are no difference in KDCS, PCS, or MCS scores between patients treated by hemodialysis and CAPD. They also got 5 more years when choose dialysis (Hemodialysis). 
 Conclusion: Health related quality of life (HRQOL) related with progressive of CKD level. The level that should pay attention is CKD level 3 where HRQOL can decreased. When the patients routine dialysis (CAPD or hemodialysis) used concern about the medicine (such erythropoietin, routine medicine) and the laboratory (albumin and hemoglobin). The more progressive level of CKD the lower of HRQOL.
 Keywords: Health Related Quality of Life (HQOL), CKD (Chronic Kidney Disease), Dialysis, Hemodialysis, Continuous Ambulatory Peritoneal Dialysis (CAPD).
Highlights
Centers for Disease and Control Preventions (CDC) (2017) recording that, in 2014, 118,000 people in the United States started the treatment for end-stage renal disease (ESRD) (End Stage Renal Disease), and 662,000 were living in a chronic dialysis or with a kidney transplant
It was found that referral type affected neither Kidney Disease Quality of Life Short Form 36 (KDQOL-36) nor Beck’s Depression Inventory (BDI) scores
The health-related quality of life (HRQOL) scores using Kidney Disease Quality of Life (KDQOL-SF) in “physical functioning (PCS)”, “symptoms and problems”, “effects of the kidney disease” and “burden of the kidney disease” were statistically and significantly lower in the Chronic Kidney Disease (CKD) G3b group compared with the CKD G3a group (90.88 ± 11.05 vs. 89.30 ± 11.52, 88.29 ± 11.94 vs. 86.49 ± 13.45, 55.86 ± 26.40 vs. 52.10 ± 27.64, 46.56 ± 8.16 vs. 44.51 ± 9.22, respectively, P< 0.01)
Summary
Centers for Disease and Control Preventions (CDC) (2017) recording that, in 2014, 118,000 people in the United States started the treatment for ESRD (End Stage Renal Disease), and 662,000 were living in a chronic dialysis or with a kidney transplant. It was estimated that there were about 199,5 million, CKD patients suffering from the disease (Zhangzhe Peng, et al, 2017). Chronic Kidney Disease (CKD) and Chronic dialysis has a great impact on patient’s health-related quality of life (HRQOL) (Yang, F., 2015)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
